Literature DB >> 28919065

Metabolically healthy obesity: the low-hanging fruit in obesity treatment?

Norbert Stefan1, Hans-Ulrich Häring2, Matthias B Schulze3.   

Abstract

Obesity increases the risk of several other chronic diseases and, because of its epidemic proportions, has become a major public health problem worldwide. Alarmingly, a lower proportion of adults have tried to lose weight during the past decade than during the mid-1980s to 1990s. The first-line treatment option for obesity is lifestyle intervention. Although this approach can decrease fat mass in the short term, these beneficial effects typically do not persist. If a large amount of weight loss is not an easily achievable goal, other goals that might motivate people with obesity to adopt a healthy lifestyle should be considered. In this setting, the concept of metabolically healthy obesity is useful. Accumulating evidence suggests that, although the risk of all-cause mortality and cardiovascular events might be higher in people with metabolically healthy obesity compared with metabolically healthy people of a normal weight, the risk is substantially lower than in individuals with metabolically unhealthy obesity. Therefore, every person with obesity should be motivated to achieve a normal weight in the long term, but more moderate weight loss sufficient for the transition from metabolically unhealthy obesity to metabolically healthy obesity might also lower the risk of adverse outcomes. However, how much weight needs to be lost for this transition to occur is under debate. This transition might be supported by lifestyle factors-such as the Mediterranean diet-that affect cardiovascular risk, independent of body fat. In this Series paper, we summarise available information about the concept of metabolically healthy obesity, highlight gaps in research, and discuss how this concept can be implemented in clinical care.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28919065     DOI: 10.1016/S2213-8587(17)30292-9

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  85 in total

1.  Edmonton obesity staging system among pediatric patients: a validation and obesogenic risk factor analysis.

Authors:  M G Grammatikopoulou; M Chourdakis; K Gkiouras; P Roumeli; D Poulimeneas; E Apostolidou; I Chountalas; I Tirodimos; O Filippou; S Papadakou-Lagogianni; T Dardavessis
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

2.  A healthy lifestyle pattern is associated with a metabolically healthy phenotype in overweight and obese adults: a cross-sectional study.

Authors:  Farah Naja; Leila Itani; Mona P Nasrallah; Hassan Chami; Hani Tamim; Lara Nasreddine
Journal:  Eur J Nutr       Date:  2019-07-30       Impact factor: 5.614

3.  Psoas and paraspinous muscle index as a predictor of mortality in African American men with type 2 diabetes mellitus.

Authors:  Mariana Murea; Leon Lenchik; Thomas C Register; Gregory B Russell; Jianzhao Xu; S Carrie Smith; Donald W Bowden; Jasmin Divers; Barry I Freedman
Journal:  J Diabetes Complications       Date:  2018-03-19       Impact factor: 2.852

4.  Weight or metabolism: which deserve more attention in obesity?

Authors:  Bing Zhu; Aaron M Gusdon; Shen Qu
Journal:  Ann Transl Med       Date:  2018-12

5.  Obesity: The myth of innocent obesity.

Authors:  Matthias Blüher
Journal:  Nat Rev Endocrinol       Date:  2017-11-09       Impact factor: 43.330

6.  Type 2 diabetes and obesity in midlife and breast cancer risk in the Reykjavik cohort.

Authors:  Gertraud Maskarinec; Álfheiður Haraldsdóttir; Kristjana Einarsdóttir; Thor Aspelund; Laufey Tryggvadóttir; Tamara B Harris; Vilmundur Gudnason; Jóhanna E Torfadóttir
Journal:  Cancer Causes Control       Date:  2019-08-10       Impact factor: 2.506

Review 7.  Metabolically Healthy Obesity and Bariatric Surgery.

Authors:  Adriana Florinela Cătoi; Luca Busetto
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

Review 8.  Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.

Authors:  Norbert Stefan; Andreas L Birkenfeld; Matthias B Schulze
Journal:  Nat Rev Endocrinol       Date:  2021-01-21       Impact factor: 43.330

Review 9.  The obesity transition: stages of the global epidemic.

Authors:  Lindsay M Jaacks; Stefanie Vandevijvere; An Pan; Craig J McGowan; Chelsea Wallace; Fumiaki Imamura; Dariush Mozaffarian; Boyd Swinburn; Majid Ezzati
Journal:  Lancet Diabetes Endocrinol       Date:  2019-01-28       Impact factor: 32.069

10.  Effectiveness of Bariatric Surgery in Patients with the Metabolically Healthy Obese Phenotype.

Authors:  Idoia Genua; Laura Tuneu; Antonio Pérez; Inka Miñambres; Analía Ramos; Nicole Stantonyonge; Francisca Caimari; Carmen Balagué; Sonia Fernández-Ananin; Jose Luis Sánchez-Quesada
Journal:  Obes Surg       Date:  2020-09-11       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.